Skip to content. | Skip to navigation

Personal tools

Navigation

You are here: Home / Clinic / News / Development of a new canine cancer therapy

Development of a new canine cancer therapy

We are excited about our collaboration with Ecrins Therapeutics, a French based pharmaceutical company, and UK's leading private small animal cancer treatment center VRCC, for the development of a new antivascular drug to fight cancer in dogs. The project is backed by the transnational programme Eurostars. It starts in April 2015 and is scheduled to run for 3 years.

Press release of Ecrins Therapeutics